Avalo Therapeutics Files Prospectus For Offering $200M Common Shares
https://www.sec.gov/Archives/edgar/data/1534120/000110465926123069/tm2628938-1_424b5.htm
Share
Why It Matters
Avalo is selling new shares to raise $200 million in cash. When a company does this, watch whether the money helps them grow or just keeps them going.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.